← Eichor
Condition: Anatomic Stage Ii Breast Cancer Ajcc V8 Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anatomic Stage Ii Breast Cancer Ajcc V8

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06401889Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT05269381Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Can
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05417308Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribocic
Phase 3 · 72 location(s) · National Cancer Institute (NCI) · NCT07391774Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NA · 1 location(s) · Fred Hutchinson Cancer Center · NCT05874297Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative
Phase 2 · 3 location(s) · City of Hope Medical Center · NCT06042569Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
Phase 2 · 7 location(s) · Jonsson Comprehensive Cancer Center · NCT05595499An Optimized Ultrasound Twinkling Marker for the Imaging of Lymph Nodes in Patients With Clinically Node-Positive Breast
Phase 1 · 1 location(s) · Mayo Clinic · NCT069997985-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
Phase 2 · 1 location(s) · Mayo Clinic · NCT07044310DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT06388122TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
NA · 4 location(s) · Dana-Farber Cancer Institute · NCT05535192Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
Phase 2 · 5 location(s) · Vanderbilt-Ingram Cancer Center · NCT05919108A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negati
Phase 2 · 1 location(s) · University of Washington · NCT07078604Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer
NA · 1 location(s) · Thomas Jefferson University · NCT04959474Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally A
Phase 2 · 1 location(s) · Mayo Clinic · NCT07460752Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT07407920Comparison Between Prepectoral and Subpectoral Breast Reconstruction
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT05833659A Study of Revaree Plus in People With Breast Cancer
Phase 4 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07042581Breast Cancer, Reasoning, and Activity Intervention
NA · 1 location(s) · Mayo Clinic · NCT04816006Breast Cancer Survivorship Biorepository
Phase N/A · 1 location(s) · University of Southern California · NCT05786664High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metast
Phase 2 · 1 location(s) · Emory University · NCT06492759A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.
NA · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT07095114Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Phase 3 · 2 location(s) · Alliance for Clinical Trials in Oncology · NCT05379153Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Can
Phase 2 · 7 location(s) · City of Hope Medical Center · NCT06954831Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-S
NA · 4 location(s) · Emory University · NCT06534125Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Phase N/A · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT00899301Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Posit
Phase 2 · 2 location(s) · City of Hope Medical Center · NCT06260033Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · 543 location(s) · National Cancer Institute (NCI) · NCT06058377Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy
Phase 3 · 3 location(s) · City of Hope Medical Center · NCT06763328Evaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Brea
Phase N/A · 5 location(s) · Mayo Clinic · NCT05417867
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.